International Journal of Chronic Obstructive Pulmonary Disease
Volume 17, 2022 - Issue
ORIGINAL RESEARCH
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
David MG Halpin1 University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UKCorrespondence[email protected]
https://orcid.org/0000-0003-2009-4406View further author information
https://orcid.org/0000-0003-2009-4406View further author information, Kieran J Rothnie2 Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UKhttps://orcid.org/0000-0003-4279-1624View further author information
https://orcid.org/0000-0003-4279-1624View further author information, Victoria Banks3 Real-World Evidence, Adelphi Real World, Bollington, UKhttps://orcid.org/0000-0002-0087-7641View further author information
https://orcid.org/0000-0002-0087-7641View further author information, Alexandrosz Czira2 Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UKhttps://orcid.org/0000-0002-3395-6186View further author information
https://orcid.org/0000-0002-3395-6186View further author information, Chris Compton4 Global Medical, GSK, London, UKhttps://orcid.org/0000-0002-7564-5343View further author information
https://orcid.org/0000-0002-7564-5343View further author information, Robert Wood3 Real-World Evidence, Adelphi Real World, Bollington, UKhttps://orcid.org/0000-0002-6977-435XView further author information
https://orcid.org/0000-0002-6977-435XView further author information, , , Rosie Wild3 Real-World Evidence, Adelphi Real World, Bollington, UKhttps://orcid.org/0000-0002-9963-6441View further author information
https://orcid.org/0000-0002-9963-6441View further author information, Neil Snowise5 Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College, London, UKhttps://orcid.org/0000-0003-1663-7404View further author information
https://orcid.org/0000-0003-1663-7404View further author information, Kirill Nikitin2 Value Evidence and Outcomes, R&D Global Medical, GSK, Brentford, UKhttps://orcid.org/0000-0003-1235-0596View further author information
https://orcid.org/0000-0003-1235-0596View further author information, , Afisi S Ismaila6 Value Evidence and Outcomes, GSK, Collegeville, PA, USA;7 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canadahttps://orcid.org/0000-0002-2876-8308View further author information
https://orcid.org/0000-0002-2876-8308View further author information & Claus F Vogelmeier8 Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germanyhttps://orcid.org/0000-0002-9798-2527View further author information
https://orcid.org/0000-0002-9798-2527View further author information show all